BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32436751)

  • 1. Gamma glutamyl transpeptidase as a prognostic biomarker in hepatocellular cancer patients especially with >5 cm tumors, treated by liver transplantation.
    Ince V; Carr BI; Bag HG; Koc C; Usta S; Ersan V; Baskiran A; Sahin TT; Yilmaz S
    Int J Biol Markers; 2020 Jun; 35(2):91-95. PubMed ID: 32436751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation.
    Fu SJ; Zhao Q; Ji F; Chen MG; Wu LW; Ren QQ; Guo ZY; He XS
    Sci Rep; 2016 Jul; 6():28835. PubMed ID: 27381639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation.
    Zhang Q; Jiao X
    Comput Math Methods Med; 2021; 2021():9809990. PubMed ID: 34845414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low alpha-fetoprotein HCC and the role of GGTP.
    Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Rapaccini GL; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F
    Int J Biol Markers; 2014 Dec; 29(4):e395-402. PubMed ID: 24832180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Value of Preoperative Gamma-Glutamyltransferase Levels in the Prognosis of AFP-Negative Hepatocellular Carcinoma.
    Lu LH; Wei-Wei ; Kan A; Jie-Mei ; Ling YH; Li SH; Guo RP
    Dis Markers; 2020; 2020():4269460. PubMed ID: 32695241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection.
    Wu SJ; Lin YX; Ye H; Xiong XZ; Li FY; Cheng NS
    Int J Surg; 2016 Dec; 36(Pt A):143-151. PubMed ID: 27793641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of preoperative serum gamma-glutamyltranspeptidase in patients with hepatocellular carcinoma after hepatectomy.
    Fu S; Guo Z; Li S; Kuang M; Hu W; Hua Y; He X; Peng B
    Tumour Biol; 2016 Mar; 37(3):3433-40. PubMed ID: 26449826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation.
    Ju MJ; Qiu SJ; Fan J; Zhou J; Gao Q; Cai MY; Li YW; Tang ZY
    J Gastroenterol; 2009; 44(6):635-42. PubMed ID: 19387533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of gamma-glutamyl transpeptidase in relation to HCC human biology and prognosis.
    Carr BI; Akkiz H; Bag HG; Karaoğullarından U; Yalçın K; Ekin N; Özakyol A; Altıntaş E; Balaban HY; Şimşek H; Uyanıkoğlu A; Balkan A; Kuran S; Üsküdar O; Ülger Y; Güney B; Delik A
    J Transl Sci; 2021 Jun; 7(3):. PubMed ID: 34540270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. γ-Glutamyltranspeptidase is a prognostic marker of survival and recurrence in radiofrequency-ablation treatment of hepatocellular carcinoma.
    Ma H; Zhang L; Tang B; Wang Y; Chen R; Zhang B; Chen Y; Ge N; Wang Y; Gan Y; Ye S; Ren Z
    Ann Surg Oncol; 2014 Sep; 21(9):3084-9. PubMed ID: 24748164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplant for large hepatocellular carcinoma in Malatya: The role of gamma glutamyl transferase and alpha-fetoprotein, a retrospective cohort study.
    Ince V; Carr BI; Bag HG; Ersan V; Usta S; Koc C; Gonultas F; Sarici BK; Karakas S; Kutluturk K; Baskiran A; Yilmaz S
    World J Gastrointest Surg; 2020 Dec; 12(12):520-533. PubMed ID: 33437403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and clinicopathological significance of Gamma-Glutamyltransferase in patients with hepatocellular carcinoma: A PRISMA-compliant meta-analysis.
    Sun P; Li Y; Chang L; Tian X
    Medicine (Baltimore); 2019 May; 98(19):e15603. PubMed ID: 31083251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma.
    Mazzaferro V; Sposito C; Zhou J; Pinna AD; De Carlis L; Fan J; Cescon M; Di Sandro S; Yi-Feng H; Lauterio A; Bongini M; Cucchetti A
    Gastroenterology; 2018 Jan; 154(1):128-139. PubMed ID: 28989060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of serum gamma-glutamyl transferase in patients with intermediate hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
    Zhang JB; Chen Y; Zhang B; Xie X; Zhang L; Ge N; Ren Z; Ye SL
    Eur J Gastroenterol Hepatol; 2011 Sep; 23(9):787-93. PubMed ID: 21730869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Preoperative Hepatocellular Carcinoma With High
    Yamao T; Yamashita YI; Imai K; Umezaki N; Tsukamoto M; Kitano Y; Arima K; Miyata T; Nakagawa S; Okabe H; Hayashi H; Chikamoto A; Ishiko T; Baba H
    Anticancer Res; 2019 Feb; 39(2):883-889. PubMed ID: 30711971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.
    Wang Y; Chen Y; Ge N; Zhang L; Xie X; Zhang J; Chen R; Wang Y; Zhang B; Xia J; Gan Y; Ren Z; Ye S
    Ann Surg Oncol; 2012 Oct; 19(11):3540-6. PubMed ID: 22532305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Patients With Hepatocellular Carcinomas That Do Not Produce α-Fetoprotein.
    Agopian VG; Harlander-Locke MP; Markovic D; Zarrinpar A; Kaldas FM; Cheng EY; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
    JAMA Surg; 2017 Jan; 152(1):55-64. PubMed ID: 27706479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of PIVKA-II After Living-donor Liver Transplantation for Hepatocellular Carcinoma.
    Park MS; Lee KW; Kim H; Choi YR; Hong G; Yi NJ; Suh KS
    Transplant Proc; 2017 Jun; 49(5):1109-1113. PubMed ID: 28583537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum tumor markers for detection of hepatocellular carcinoma.
    Zhou L; Liu J; Luo F
    World J Gastroenterol; 2006 Feb; 12(8):1175-81. PubMed ID: 16534867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype.
    Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Ludovico Rapaccini G; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Semin Oncol; 2014 Apr; 41(2):252-8. PubMed ID: 24787296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.